1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one and Neoplasms

1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one has been researched along with Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Acuna, SA; Atkins, H; Auer, RC; Bell, JC; Breitbach, CJ; Evgin, L; Falls, T; Findlay, CS; Goldstein, A; Hanwell, D; Ilkow, CS; Kirn, D; Lafrance, S; Lambris, JD; Lemay, CG; Lopez, R; Marguerie, M; McCart, JA; Parato, KA; Stahl, GL; Tanese de Souza, C; Thurman, JM	1

Other Studies

1 other study(ies) available for 1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one and Neoplasms

Article	Year
Complement inhibition prevents oncolytic vaccinia virus neutralization in immune humans and cynomolgus macaques. Molecular therapy : the journal of the American Society of Gene Therapy, 2015, Volume: 23, Issue:6 Topics: Animals; Antibodies, Viral; Cell Line, Tumor; Chlorocebus aethiops; Disease Models, Animal; Drug Delivery Systems; Feasibility Studies; Female; HeLa Cells; Humans; Injections, Intralesional; Macaca fascicularis; Male; Neoplasms; Neutralization Tests; Oncolytic Virotherapy; Oncolytic Viruses; Pyridones; Rats; Rats, Inbred F344; Smallpox Vaccine; Vaccination; Vaccinia virus; Vero Cells	2015

Article

Year

Complement inhibition prevents oncolytic vaccinia virus neutralization in immune humans and cynomolgus macaques.

Molecular therapy : the journal of the American Society of Gene Therapy, 2015, Volume: 23, Issue:6

Topics: Animals; Antibodies, Viral; Cell Line, Tumor; Chlorocebus aethiops; Disease Models, Animal; Drug Delivery Systems; Feasibility Studies; Female; HeLa Cells; Humans; Injections, Intralesional; Macaca fascicularis; Male; Neoplasms; Neutralization Tests; Oncolytic Virotherapy; Oncolytic Viruses; Pyridones; Rats; Rats, Inbred F344; Smallpox Vaccine; Vaccination; Vaccinia virus; Vero Cells

2015